Tyrosine kinase 2 inhibition improves clinical and molecular hallmarks in subtypes of cutaneous lupus

Sophia Wasserer, Peter Seiringer, Nils Kurzen, Manja Jargosch, Jessica Eigemann, Görkem Aydin, Theresa Raunegger, Carsten B Schmidt-Weber, Stefanie Eyerich, Tilo Biedermann, Kilian Eyerich, Felix Lauffer

Open source

DOI: 10.1093/bjd/ljaf293
Published: 2025-08-08
Container: British Journal of Dermatology
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/bjd/ljaf293,
  title = {Tyrosine kinase 2 inhibition improves clinical and molecular hallmarks in subtypes of cutaneous lupus},
  author = {Sophia Wasserer and Peter Seiringer and Nils Kurzen and Manja Jargosch and Jessica Eigemann and Görkem Aydin and Theresa Raunegger and Carsten B Schmidt-Weber and Stefanie Eyerich and Tilo Biedermann and Kilian Eyerich and Felix Lauffer},
  year = {2025},
  journal = {British Journal of Dermatology},
  doi = {10.1093/bjd/ljaf293},
  url = {https://doi.org/10.1093/bjd/ljaf293}
}

RIS

TY  - JOUR
TI  - Tyrosine kinase 2 inhibition improves clinical and molecular hallmarks in subtypes of cutaneous lupus
AU  - Sophia Wasserer
AU  - Peter Seiringer
AU  - Nils Kurzen
AU  - Manja Jargosch
AU  - Jessica Eigemann
AU  - Görkem Aydin
AU  - Theresa Raunegger
AU  - Carsten B Schmidt-Weber
AU  - Stefanie Eyerich
AU  - Tilo Biedermann
AU  - Kilian Eyerich
AU  - Felix Lauffer
PY  - 2025
JO  - British Journal of Dermatology
DO  - 10.1093/bjd/ljaf293
UR  - https://doi.org/10.1093/bjd/ljaf293
ER  -

APA

Wasserer, S., Seiringer, P., Kurzen, N., Jargosch, M., Eigemann, J., Aydin, G., Raunegger, T., Schmidt-Weber, C. B., Eyerich, S., Biedermann, T., Eyerich, K., & Lauffer, F. (2025). Tyrosine kinase 2 inhibition improves clinical and molecular hallmarks in subtypes of cutaneous lupus. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljaf293

Source records

crossref · retrieved 2026-11-08T10:13:28.829Z